Volver al buscador
CPSCCPSC · Productos de consumo·N.º oficial 20091

Sandimmune® (cyclosporine capsules, USP) 100 mg soft gelatin capsules and Neoral® (cyclosporine capsules, USP) MODIFIED 100 mg soft gelatin capsules prescription drug blister packages

Publicado el 18 de marzo de 2020 · Inicio del retiro: 18 de marzo de 2020

Qué peligro representa

The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act (PPPA), posing a risk of poisoning if the contents are swallowed by young children.

Qué hacer

Consumers should immediately secure the product out of the sight and reach of children and contact the firm to request a free child-resistant pouch in which to store the blister package medications. Consumers can continue to use the medication as directed. The child-resistant pouches should be used to store these medications until new child-resistant blister packaging is available.

Detalles del retiro

Distribuidor
Novartis Pharmaceuticals Corporation, of East Hanover, N.J.
País
US
Ver aviso oficial de CPSC